Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992644071> ?p ?o ?g. }
- W1992644071 endingPage "739" @default.
- W1992644071 startingPage "738" @default.
- W1992644071 abstract "In the April issue of HEPATOLOGY, Marrero et al.1 reported that the Barcelona Clinic Liver Cancer (BCLC) “staging classification” provided the best prognostic stratification for patients with hepatocellular carcinoma (HCC). Their staging validation, however, is limited by critical shortcomings. The BCLC algorithm prescribes palliative therapies (ablation, chemoembolization) to many patients who may be candidates for resection. The University of Michigan (UM) algorithm similarly excludes patients from potentially curative therapy by using the same criteria. The retrospective application of such a treatment-based “staging” to their patients predictably showed that the outcomes of the BCLC and UM algorithms are congruous. The proof that the algorithms from UM and BCLC predict prognosis based on treatment and not by disease is the disparity in survival for patients who met the Milan criteria. Both groups propose either transplantation or ablation for patients with a solitary tumor ≤ 5 cm or up to 3 tumors ≤ 3 cm, but Fig, 2B reveals significantly different survival based not on disease, but rather only on treatment—the best survival in the transplantation group, the worst survival in the ablation group—despite different treatments being given to patients with the same disease (stage A in BCLC algorithm). Although the authors state that the study groups were “balanced,” the treatments do not reflect this; most patients in the study had advanced disease (cirrhosis, 98%; multiple tumors, 56%) and only 4% underwent resection. Given that 100 patients were Child-Turcotte-Pugh Classification A, and 222 had unilateral disease, potentially curative resection might have been offered to a significant subgroup. For example, patients with solitary HCC > 5 cm or multiple tumors > 3 cm (stage B in BCLC algorithm) might have been considered for resection, but were instead treated exclusively with chemoembolization. Such palliative treatment is not consistent with the existing approach taken at many major hepatobiliary centers. Ng et al.2 reported a 5-year survival rate of 39% after resection of large or multinodular HCC (Stage B in BCLC algorithm). Pawlik et al.3 reported a 5-year survival rate of 27% after resection in well-selected patients with HCC measuring ≥10 cm. These results suggest that the use of strict morphological criteria to exclude patients from surgical consideration is inappropriate. Categorical exclusion of patients from resection, as proposed by the BCLC and by Marrero et al.,1 also precludes identification of factors predictive of survival or selection factors for optimal treatment if that therapy is not undertaken. In 2002, the AJCC/UICC adopted a simplified staging for HCC.4 This staging was based on a detailed evaluation of tumor and liver factors associated with HCC. The study included patients from hepatobiliary centers in Japan, France, and the United States.5 More recently, this staging was independently validated in eastern and western patients undergoing resection for HCC.6-8 We agree with Marrero et al. that the lack of a consensus on HCC staging hinders progress in critical areas of HCC research. However, given the heterogeneity of patients with HCC, a need remains for alternate stagings and treatment algorithms. Timothy M. Pawlik*, Eddie K. Abdalla*, Melanie Thomas , Mark S. Roh , Gregory Y. Lauwers?, Dario Ribero*, Ronnie T. Poon?, Jacques Belghiti**, David M. Nagorney , Jean-Nicolas Vauthey*, * Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, Department of Surgical Oncology, Allegheny General Hospital, Pittsburgh, PA, ? Department of Gastrointestinal Pathology, Massachusetts General Hospital, Boston, MA, ? Department of Surgery, Queen Mary Hospital, Hong Kong, China, ** Department of Surgery, Hospital Beaujon, Paris, France, Department of General Surgery, Mayo Clinic, Rochester, MN." @default.
- W1992644071 created "2016-06-24" @default.
- W1992644071 creator A5011547093 @default.
- W1992644071 creator A5035763230 @default.
- W1992644071 creator A5037326704 @default.
- W1992644071 creator A5043349288 @default.
- W1992644071 creator A5053504765 @default.
- W1992644071 creator A5055720674 @default.
- W1992644071 creator A5058146274 @default.
- W1992644071 creator A5059293493 @default.
- W1992644071 creator A5061731153 @default.
- W1992644071 creator A5063597784 @default.
- W1992644071 creator A5067287435 @default.
- W1992644071 creator A5077140895 @default.
- W1992644071 creator A5084427458 @default.
- W1992644071 creator A5085656655 @default.
- W1992644071 creator A5089897151 @default.
- W1992644071 date "2005-01-01" @default.
- W1992644071 modified "2023-10-14" @default.
- W1992644071 title "Staging of hepatocellular carcinoma" @default.
- W1992644071 cites W1974060646 @default.
- W1992644071 cites W2090293099 @default.
- W1992644071 cites W2104910193 @default.
- W1992644071 cites W2121904561 @default.
- W1992644071 cites W2154605870 @default.
- W1992644071 cites W3148043070 @default.
- W1992644071 cites W4239180165 @default.
- W1992644071 cites W4253752771 @default.
- W1992644071 doi "https://doi.org/10.1002/hep.20849" @default.
- W1992644071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16116639" @default.
- W1992644071 hasPublicationYear "2005" @default.
- W1992644071 type Work @default.
- W1992644071 sameAs 1992644071 @default.
- W1992644071 citedByCount "4" @default.
- W1992644071 countsByYear W19926440712021 @default.
- W1992644071 crossrefType "journal-article" @default.
- W1992644071 hasAuthorship W1992644071A5011547093 @default.
- W1992644071 hasAuthorship W1992644071A5035763230 @default.
- W1992644071 hasAuthorship W1992644071A5037326704 @default.
- W1992644071 hasAuthorship W1992644071A5043349288 @default.
- W1992644071 hasAuthorship W1992644071A5053504765 @default.
- W1992644071 hasAuthorship W1992644071A5055720674 @default.
- W1992644071 hasAuthorship W1992644071A5058146274 @default.
- W1992644071 hasAuthorship W1992644071A5059293493 @default.
- W1992644071 hasAuthorship W1992644071A5061731153 @default.
- W1992644071 hasAuthorship W1992644071A5063597784 @default.
- W1992644071 hasAuthorship W1992644071A5067287435 @default.
- W1992644071 hasAuthorship W1992644071A5077140895 @default.
- W1992644071 hasAuthorship W1992644071A5084427458 @default.
- W1992644071 hasAuthorship W1992644071A5085656655 @default.
- W1992644071 hasAuthorship W1992644071A5089897151 @default.
- W1992644071 hasBestOaLocation W19926440711 @default.
- W1992644071 hasConcept C126322002 @default.
- W1992644071 hasConcept C141071460 @default.
- W1992644071 hasConcept C143998085 @default.
- W1992644071 hasConcept C146357865 @default.
- W1992644071 hasConcept C151730666 @default.
- W1992644071 hasConcept C2776231280 @default.
- W1992644071 hasConcept C2776282453 @default.
- W1992644071 hasConcept C2777075537 @default.
- W1992644071 hasConcept C2777214474 @default.
- W1992644071 hasConcept C2777377203 @default.
- W1992644071 hasConcept C2778019345 @default.
- W1992644071 hasConcept C2778902805 @default.
- W1992644071 hasConcept C2779134260 @default.
- W1992644071 hasConcept C2779609443 @default.
- W1992644071 hasConcept C2911091166 @default.
- W1992644071 hasConcept C41260117 @default.
- W1992644071 hasConcept C71924100 @default.
- W1992644071 hasConcept C86803240 @default.
- W1992644071 hasConcept C90924648 @default.
- W1992644071 hasConceptScore W1992644071C126322002 @default.
- W1992644071 hasConceptScore W1992644071C141071460 @default.
- W1992644071 hasConceptScore W1992644071C143998085 @default.
- W1992644071 hasConceptScore W1992644071C146357865 @default.
- W1992644071 hasConceptScore W1992644071C151730666 @default.
- W1992644071 hasConceptScore W1992644071C2776231280 @default.
- W1992644071 hasConceptScore W1992644071C2776282453 @default.
- W1992644071 hasConceptScore W1992644071C2777075537 @default.
- W1992644071 hasConceptScore W1992644071C2777214474 @default.
- W1992644071 hasConceptScore W1992644071C2777377203 @default.
- W1992644071 hasConceptScore W1992644071C2778019345 @default.
- W1992644071 hasConceptScore W1992644071C2778902805 @default.
- W1992644071 hasConceptScore W1992644071C2779134260 @default.
- W1992644071 hasConceptScore W1992644071C2779609443 @default.
- W1992644071 hasConceptScore W1992644071C2911091166 @default.
- W1992644071 hasConceptScore W1992644071C41260117 @default.
- W1992644071 hasConceptScore W1992644071C71924100 @default.
- W1992644071 hasConceptScore W1992644071C86803240 @default.
- W1992644071 hasConceptScore W1992644071C90924648 @default.
- W1992644071 hasIssue "3" @default.
- W1992644071 hasLocation W19926440711 @default.
- W1992644071 hasLocation W19926440712 @default.
- W1992644071 hasOpenAccess W1992644071 @default.
- W1992644071 hasPrimaryLocation W19926440711 @default.
- W1992644071 hasRelatedWork W1484235223 @default.
- W1992644071 hasRelatedWork W159125119 @default.
- W1992644071 hasRelatedWork W2008626862 @default.